Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of $104.85 billion. The enterprise value is $124.40 billion.
| Market Cap | 104.85B |
| Enterprise Value | 124.40B |
Important Dates
The last earnings date was Wednesday, June 3, 2026, before market open.
| Earnings Date | Jun 3, 2026 |
| Ex-Dividend Date | Jun 26, 2026 |
Share Statistics
Medtronic has 1.28 billion shares outstanding. The number of shares has decreased by -0.14% in one year.
| Current Share Class | 1.28B |
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | -0.14% |
| Shares Change (QoQ) | -0.10% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 88.59% |
| Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 21.90 and the forward PE ratio is 13.73. Medtronic's PEG ratio is 2.48.
| PE Ratio | 21.90 |
| Forward PE | 13.73 |
| PS Ratio | 2.88 |
| Forward PS | 2.74 |
| PB Ratio | 2.14 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 19.32 |
| P/OCF Ratio | 14.30 |
| PEG Ratio | 2.48 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.34, with an EV/FCF ratio of 22.93.
| EV / Earnings | 25.91 |
| EV / Sales | 3.42 |
| EV / EBITDA | 12.34 |
| EV / EBIT | 17.46 |
| EV / FCF | 22.93 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.57 |
| Debt / EBITDA | 2.78 |
| Debt / FCF | 5.17 |
| Interest Coverage | 9.96 |
Financial Efficiency
Return on equity (ROE) is 9.93% and return on invested capital (ROIC) is 8.15%.
| Return on Equity (ROE) | 9.93% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 8.15% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.37% |
| Revenue Per Employee | $382,779 |
| Profits Per Employee | $50,537 |
| Employee Count | 95,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Medtronic has paid $1.30 billion in taxes.
| Income Tax | 1.30B |
| Effective Tax Rate | 21.17% |
Stock Price Statistics
The stock price has decreased by -4.59% in the last 52 weeks. The beta is 0.60, so Medtronic's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -4.59% |
| 50-Day Moving Average | 81.31 |
| 200-Day Moving Average | 92.46 |
| Relative Strength Index (RSI) | 59.34 |
| Average Volume (20 Days) | 11,947,259 |
Short Selling Information
The latest short interest is 14.65 million, so 1.14% of the outstanding shares have been sold short.
| Short Interest | 14.65M |
| Short Previous Month | 15.46M |
| Short % of Shares Out | 1.14% |
| Short % of Float | 1.14% |
| Short Ratio (days to cover) | 1.50 |
Income Statement
In the last 12 months, Medtronic had revenue of $36.36 billion and earned $4.80 billion in profits. Earnings per share was $3.73.
| Revenue | 36.36B |
| Gross Profit | 23.78B |
| Operating Income | 7.12B |
| Pretax Income | 6.14B |
| Net Income | 4.80B |
| EBITDA | 10.08B |
| EBIT | 7.12B |
| Earnings Per Share (EPS) | $3.73 |
Balance Sheet
The company has $8.38 billion in cash and $28.07 billion in debt, with a net cash position of -$19.54 billion or -$15.22 per share.
| Cash & Cash Equivalents | 8.38B |
| Total Debt | 28.07B |
| Net Cash | -19.54B |
| Net Cash Per Share | -$15.22 |
| Equity (Book Value) | 49.20B |
| Book Value Per Share | 38.17 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was $7.33 billion and capital expenditures -$1.90 billion, giving a free cash flow of $5.43 billion.
| Operating Cash Flow | 7.33B |
| Capital Expenditures | -1.90B |
| Depreciation & Amortization | 2.96B |
| Net Borrowing | -1.17B |
| Free Cash Flow | 5.43B |
| FCF Per Share | $4.23 |
Margins
Gross margin is 65.38%, with operating and profit margins of 19.59% and 13.20%.
| Gross Margin | 65.38% |
| Operating Margin | 19.59% |
| Pretax Margin | 16.88% |
| Profit Margin | 13.20% |
| EBITDA Margin | 27.72% |
| EBIT Margin | 19.59% |
| FCF Margin | 14.92% |
Dividends & Yields
This stock pays an annual dividend of $2.84, which amounts to a dividend yield of 3.48%.
| Dividend Per Share | $2.84 |
| Dividend Yield | 3.48% |
| Dividend Growth (YoY) | 1.42% |
| Years of Dividend Growth | 50 |
| Payout Ratio | 76.41% |
| Buyback Yield | 0.14% |
| Shareholder Yield | 3.62% |
| Earnings Yield | 4.58% |
| FCF Yield | 5.17% |
Analyst Forecast
The average price target for Medtronic is $98.58, which is 20.71% higher than the current price. The consensus rating is "Buy".
| Price Target | $98.58 |
| Price Target Difference | 20.71% |
| Analyst Consensus | Buy |
| Analyst Count | 30 |
| Revenue Growth Forecast (3Y) | 4.07% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 27, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |